Suvorexant alters dynamics of the sleep-EEG power spectrum and depressive symptom trajectories during inpatient opioid withdrawal.

Matthew J ReidKelly E DunnLiza AbrahamJennifer Danielle EllisCarly HuntCharlene E GamaldoWilliam G CoonChung Jung MunEric C StrainMichael T SmithPatrick H Finan Andrew S Huhn

Published in: Sleep (2024)

Results highlight a complex and nuanced relationship between sleep EEG power and symptoms of depression and withdrawal. Changes in delta power may represent a mechanism influencing depressive symptoms and withdrawal.

Keyphrases

depressive symptoms
sleep quality
functional connectivity
resting state
social support
working memory
physical activity
chronic pain
pain management
mental health
bipolar disorder
palliative care